Brief: Amneal Announces Expanded Coverage For Crexont® To Enhance Access For Parkinson’S Disease Patients In The U.S.
03/04/2025 13:09
April 3 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL ANNOUNCES EXPANDED COVERAGE FOR CREXONT® (CARBIDOPA AND LEVODOPA) TO ENHANCE ACCESS FOR PARKINSON’S DISEASE PATIENTS IN THE U.S. Source text: ID:nBw4yQPKPa Further company coverage: AMRX.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary